1
Safety Study of Crushed Deferasirox Film Coated Tablets in Pediatric Patients With Transfusional Hemosiderosis
Condition(s):Iron OverloadLast Updated:August 25, 2020Completed
Deferasirox: 109 Clinical Trials, Page 1 of 11
Hide Studies Not Open or Pending
2
Open-label, Multicenter Study Assessing Preference for Deferasirox Film-coated Tablet Compared to Dispersible Tablet
Condition(s):Transfusion-dependent Thalassemia; Non-transfusion-dependent ThalassemiaLast Updated:October 4, 2021Completed
3
Deferasirox BID (Twice a Day) in Transfusion Dependent Thalassemia Patients With Inadequate Response to High Doses
Condition(s):Focus on Transfusion Dependent Thalassemia Patients Who Are Inadequate Responders to Deferasirox > 35mg/kgQDLast Updated:April 20, 2017Withdrawn
4
An Open Label Study to Evaluate the Pharmacokinetics, Safety, Tolerability and Efficacy of Deferasirox Administered to Chinese Patients With β-thalassemia Major Aged From 2 to Less Than 6 Years Old
Condition(s):β-thalassemia MajorLast Updated:April 20, 2017Withdrawn
5
Efficacy and Safety Study of Deferasirox in Patients With Non-transfusion Dependent Thalassemia
Condition(s):Non-transfusion Dependent ThalassemiaLast Updated:October 2, 2019Completed
6
Study to Evaluate the Efficacy and Safety of Deferasirox Film-coated Tablet Versus Phlebotomy in Patients With Hereditary Hemochromatosis (HH)
Condition(s):Hereditary HemochromatosisLast Updated:May 18, 2023Completed
7
Palatability and Tolerability of Deferasirox Taken With Meals, With Different Liquids or Crushed and Added to Food
Condition(s):Transfusional HemosiderosisLast Updated:July 20, 2021Completed
8
A Phase II Pilot Study to Assess the Presence of Molecular Factors Predictive for Hematologic Response in Myelodysplastic Syndrome Patients Receiving Deferasirox Therapy.
Condition(s):Myelodysplastic SyndromeLast Updated:August 23, 2018Terminated
9
Deferasirox in Treating Patients With Very Low, Low, or Intermediate-Risk Red Blood Cell Transfusion Dependent Anemia or Myelodysplastic Syndrome
Condition(s):Anemia; Myelodysplastic SyndromeLast Updated:July 1, 2020Terminated
10
Renal Function Among Thalassemia Patients Treated by a Oral Chelator Deferasirox
Condition(s):Thalassemia; Iron OverloadLast Updated:September 1, 2015Completed